Active surveillance failure for prostate cancer:  does the delay in treatment increase the risk of urinary incontinence?
The UI rates in our cohort of active surveillance patients who move on to active treatment are similar to patients who undergo treatment immediately after prostate cancer is diagnosed as quoted in the literature.  This suggests that active surveillance, as an initial mode of therapy, does not increase the risk of UI if active treatment occurs at a later date.
Oral sesame oil is therapeutically ineffectual against monocrotaline-induced SOS.